Dendreon Corp fka DNDNQ

[phojo]

<<Given such a large short position in the stock and its current low market cap, DNDN is a coiled spring. Dew knows that positive FDA news (step 1 acceptance of BLA, step 2 not overly negative briefing docs, step 3 thumbs up panel reco) would set that spring off.
>>

You have previously mentioned the weight of the mid East conflict on the market. Does anyone have a guess as to the impact of such events on DNDN, in particular. For instance, some companies withold the announcement of a spin-off etc. until the market calms. I know that Dendreon would not do such a thing with a drug that could extend the lives of hundreds of thousands of men but can a company bring a drug to the market and still expect the same price estimates during this bearish market? Does anyone with past experience in the bio field or investing have a forcast or example they would care to share? I will hold through it all and pray for a quick resolve.


Thanks walldiver for sharing and taking the time to moderate this board.

Go Long,

joe